How can we help you?
Get in touch with one of our Xperts.
Why we are unique
Full development support
Both strategic and operational
Speed up development programs and increase efficiency
Knowledge Transfer
Direct access to highly experienced consultants in various therapeutic areas and indications
Flexible deployment of experts
Cost and time effective
To meet the timeline, budget, regulatory and quality requirements
Vast network in the industry
Contract negotiation with CROs and C(D)MOs
Due diligence, valuation and venture capture
Our mission is to partner with you from early on to the very end.
We’re proud to provide continous support to Khondrion as an important milestone is reached in the Phase 3 KHENERFIN study with the treatment of the first patient
The first patient has been dosed in the pivotal Phase 3 KHENERFIN study evaluating sonlicromanol for the treatment of m.3243A>G primary mitochondrial disease. This milestone marks an important step in…
Identity analytics: For cell-based therapies, the analytics, in addition to the process, are the product
Introduction As pharmaceutical drugs become physically larger, from small molecules to biologics to gene and cell therapies, so their molecular complexity increases. Small molecule drugs can be defined at the…